Nuo Therapeutics, Inc. (AURX) Insider Trading

Name: Nuo Therapeutics, Inc. (AURX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 28, 2026): JORDEN DAVID EMERSON (CEO/CFO): Grant/Award of 789 shares, $844.23.

Get alerted when insiders trade AURX

Email address

Loading company data...

Beta

Loading company details...

Beta